Cargando…
Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques
BACKGROUND: Cardiovascular disease (CVD) is the foremost cause of morbidity and deaths in antiphospholipid syndrome (APS), driven by thrombo-inflammation and atherothrombosis mechanisms. Metabolic syndrome (MetS) is a proinflammatory and prothrombotic state characterized by increased CVD risk. We ai...
Autores principales: | Bolla, Eleana, Tentolouris, Nikolaos, Sfikakis, Petros P., Tektonidou, Maria G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868803/ https://www.ncbi.nlm.nih.gov/pubmed/36700208 http://dx.doi.org/10.3389/fimmu.2022.1077166 |
Ejemplares similares
-
Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus
por: Bolla, Eleana, et al.
Publicado: (2021) -
Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus
por: Fragoulis, George E., et al.
Publicado: (2020) -
Stress perfusion Cardiac Magnetic Resonance in Patients with Antiphospholipid Syndrome
por: Tektonidou, Maria G., et al.
Publicado: (2018) -
Application of EULAR and European Society of Cardiology recommendations with regard to blood pressure and lipid management in antiphospholipid syndrome
por: Drosos, George C, et al.
Publicado: (2023) -
Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools
por: Drosos, George C, et al.
Publicado: (2023)